VBI Vaccines
VBIV
#10530
Rank
A$2.82 M
Marketcap
A$0.09834
Share price
0.00%
Change (1 day)
-89.74%
Change (1 year)

VBI Vaccines (VBIV) - Cash on Hand

Cash on Hand as of March 2024 : A$18.96 Million

According to VBI Vaccines 's latest financial reports the company has A$18.96 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

VBI Vaccines - Cash on Hand chart (from 1997 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$92.03 M-45.17%
2021-12-31A$0.16 B8.37%
2020-12-31A$0.15 B145.28%
2019-12-31A$63.14 M-24.94%
2018-12-31A$84.13 M-2.97%
2017-12-31A$86.7 M93.61%
2016-12-31A$44.78 M161.5%
2015-12-31A$17.12 M
2015-03-31A$51.78 M27.28%
2014-03-31A$40.68 M-12.6%
2013-03-31A$46.55 M-16.96%
2012-03-31A$56.06 M183.31%
2011-03-31A$19.78 M808.18%
2010-03-31A$2.17 M523.51%
2009-03-31A$0.34 M31.26%
2008-03-31A$0.26 M-62.29%
2007-03-31A$0.7 M-24.77%
2006-03-31A$0.93 M1296.15%
2005-03-31A$0.06 M-75.45%
2004-03-31A$0.27 M109.38%
2003-03-31A$0.13 M843.09%
2002-03-31A$0.01 M11.96%
2001-03-31A$0.01 M
1997-03-31A$0.18 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Onconova Therapeutics
ONTX
A$24.68 M 30.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A$0.21 B 1,054.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$13.63 M-28.14%๐Ÿ‡บ๐Ÿ‡ธ USA